Strategic Global Advisors LLC Purchases Shares of 8,136 HCA Healthcare, Inc. $HCA

Strategic Global Advisors LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 8,136 shares of the company’s stock, valued at approximately $3,798,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Towarzystwo Funduszy Inwestycyjnych PZU SA raised its stake in shares of HCA Healthcare by 6.8% in the fourth quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 943 shares of the company’s stock worth $440,000 after purchasing an additional 60 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its stake in shares of HCA Healthcare by 4.9% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 40,456 shares of the company’s stock worth $18,887,000 after purchasing an additional 1,872 shares during the last quarter. Panagora Asset Management Inc. raised its stake in shares of HCA Healthcare by 10.6% in the fourth quarter. Panagora Asset Management Inc. now owns 210,905 shares of the company’s stock worth $98,463,000 after purchasing an additional 20,181 shares during the last quarter. Piedmont Capital Management LLC NC purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $229,000. Finally, Focus Partners Wealth raised its stake in shares of HCA Healthcare by 355.5% in the fourth quarter. Focus Partners Wealth now owns 43,193 shares of the company’s stock worth $20,142,000 after purchasing an additional 33,711 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.0%

Shares of HCA opened at $387.25 on Monday. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The stock’s 50 day moving average is $429.60 and its two-hundred day moving average is $473.29. The firm has a market cap of $85.91 billion, a P/E ratio of 13.32, a PEG ratio of 1.23 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the business posted $6.45 earnings per share. The firm’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research analyst reports. Argus reduced their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Jefferies Financial Group reiterated a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Stephens reduced their price target on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Robert W. Baird reduced their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Finally, TD Cowen reduced their price target on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Company Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.